D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4026
CALL
PAR Technology
PAR
$654M
| $252K | ﹤0.01% |
18,900
-2,100
| -10% | -$49.3K |
2025 Q3
2 quarters
|
|
4027
MBIA
MBI
$224M
| $252K | ﹤0.01% |
42,616
-19,987
| -32% | -$127K |
2022 Q4
13 quarters
|
|
4028
Invesco S&P 500 High Beta ETF
SPHB
$938M
| $251K | ﹤0.01% |
2,168
-500
| -19% | -$60.5K |
2023 Q4
9 quarters
|
|
4029
Oil-Dri
ODC
$1.24B
| $251K | ﹤0.01% |
3,859
-8,032
| -68% | -$489K |
2025 Q2
3 quarters
|
|
4030
CALL
Titan Machinery
TITN
$536M
| $251K | ﹤0.01% |
15,000
+4,800
| +47% | +$83.3K |
2025 Q1
4 quarters
|
|
4031
American Public Education
APEI
$885M
| $250K | ﹤0.01% |
+4,390
| New | +$201K |
2026 Q1
0 quarters
|
|
4032
Fidelity MSCI Communication Services Index ETF
FCOM
$1.84B
| $249K | ﹤0.01% |
+3,655
| New | +$263K |
2026 Q1
0 quarters
|
|
4033
Corbus Pharmaceuticals
CRBP
$85.3M
| $249K | ﹤0.01% |
26,474
-2,320
| -8% | -$19.5K |
2025 Q3
2 quarters
|
|
4034
PUT
Zoetis
ZTS
$31.1B
| $248K | ﹤0.01% |
2,100
| – | – |
2025 Q4
1 quarter
|
|
4035
BitGo Holdings
BTGO
$737M
| $248K | ﹤0.01% |
+30,094
| New | +$329K |
2026 Q1
0 quarters
|
|
4036
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $247K | ﹤0.01% |
4,700
| – | – |
2023 Q4
9 quarters
|
|
4037
Transmedics
TMDX
$2.62B
| $247K | ﹤0.01% |
+2,481
| New | +$324K |
2026 Q1
0 quarters
|
|
4038
Sierra Bancorp
BSRR
$504M
| $246K | ﹤0.01% |
7,256
-2,735
| -27% | -$95.6K |
2025 Q4
1 quarter
|
|
4039
PUT
Thermo Fisher Scientific
TMO
$249B
| $246K | ﹤0.01% |
500
-6,100
| -92% | -$3.31M |
2024 Q4
5 quarters
|
|
4040
CALL
Hawkins
HWKN
$2.74B
| $246K | ﹤0.01% |
1,600
-900
| -36% | -$132K |
2025 Q4
1 quarter
|
|
4041
Hilton Worldwide
HLT
$73.8B
| $245K | ﹤0.01% |
807
-26,862
| -97% | -$8.14M |
2021 Q3
18 quarters
|
|
4042
Provident Financial Services
PFS
$2.86B
| $245K | ﹤0.01% |
+11,572
| New | +$247K |
2026 Q1
0 quarters
|
|
4043
Aurora Cannabis
ACB
$264M
| $243K | ﹤0.01% |
74,117
-1,941
| -3% | -$7.33K |
2025 Q3
2 quarters
|
|
4044
CALL
Dutch Bros
BROS
$5.4B
| $243K | ﹤0.01% |
4,800
-142,100
| -97% | -$7.77M |
2025 Q2
3 quarters
|
|
4045
Ascendis Pharma A/S
ASND
$14.9B
| $243K | ﹤0.01% |
1,062
-124,706
| -99% | -$28M |
2018 Q1
32 quarters
|
|
4046
CALL
Transcat
TRNS
$771M
| $242K | ﹤0.01% |
3,300
-11,200
| -77% | -$788K |
2025 Q3
2 quarters
|
|
|
HVIIR
4047
DELISTED
Hennessy Capital Investment Corp VII Rights
HVIIR
| $242K | ﹤0.01% |
850,000
| – | – |
2025 Q1
4 quarters
|
|
4048
AB Disruptors ETF
FWD
$3.34B
| $242K | ﹤0.01% |
2,227
| – | – |
2025 Q3
2 quarters
|
|
4049
Universal Health Realty Income Trust
UHT
$524M
| $241K | ﹤0.01% |
+5,963
| New | +$247K |
2026 Q1
0 quarters
|
|
4050
Hackett Group
HCKT
$281M
| $241K | ﹤0.01% |
18,534
-69,402
| -79% | -$1.11M |
2025 Q1
4 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.